INVIVYD INC (IVVD) Stock Price, Quote, News and Overview
NASDAQ:IVVD - Nasdaq - US00534A1025 - Common Stock - Currency: USD
IVVD Quote, Performance and Key Statistics
INVIVYD INC
NASDAQ:IVVD (1/30/2025, 1:23:55 PM)
0.3789
-0.01 (-1.66%)
The current stock price of IVVD is 0.3789 USD. In the past month the price decreased by -24.45%. In the past year, price decreased by -91.8%.
IVVD Latest News, Press Releases and Analysis
Curious about the stocks that are showing activity after the closing bell on Monday?
Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on stock movements.
Get insights into the top gainers and losers of Friday's pre-market session.
Invivyd Provides Another Positive SARS-CoV-2 Variant Data Analysis to Satisfy U.S. FDA’s Gating Request for Completing Its Review of EUA Request for PEMGARDA™ (pemivibart) for the Treatment of Mild-to-Moderate COVID-19 in Certain Immunocompromised
Treatment immunobridging analysis, routinely updated for contemporary SARS-CoV-2 variants, compares pemivibart antiviral titers to adintrevimab antiviral...
What's Going On With COVID-19 Antibody Developer Invivyd Stock On Friday?
On Friday, Invivyd Inc. (NASDAQ:IVVD) announced that new in vitro neutralization data show continued neutralizing activity of Pemgarda (pemivibart) and pipeline candidate VYD2311 against dominant SARS-CoV-2 variant XEC. The stock is trading with a strong session volume of 12.3 million, compared to an average volume of 757.02k as per data from Benzinga Pro. As anticipated, the data are largely consistent with those previously reported for KP.3.1.1, based on the structural biology of pemivibart an
What's Going On With COVID-19 Antibody Developer Invivyd Stock On Friday?
Invivyd's new data highlights Pemgarda's activity against SARS-CoV-2 XEC and over 75% of variants, with consistent neutralization since Omicron BA.1.
IVVD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.35 | 310.57B | ||
| AMGN | AMGEN INC | 14.81 | 153.03B | ||
| GILD | GILEAD SCIENCES INC | 21.79 | 120.31B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 867.24 | 113.90B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.06 | 75.18B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.76B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.61B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.75B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.26B | ||
| NTRA | NATERA INC | N/A | 23.23B | ||
| BIIB | BIOGEN INC | 9.04 | 21.51B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.50B |
Related stock screener links
About IVVD
Company Profile
Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is headquartered in Waltham, Massachusetts and currently employs 94 full-time employees. The company went IPO on 2021-08-06. The Company’s proprietary INVYMAB platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral threats. The firm delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2 (COVID-19). Its PEMGARDA is the Company’s first mAb in a planned series of innovative mAb candidates designed to keep pace with SARS-CoV-2 viral evolution. Its VYD2311 is optimized for neutralization potency against recent SARS-CoV-2 lineages such as BA.2.86 and JN.1. The firm also has additional anti-SARS-CoV-2 mAb candidates in discovery and pre-clinical characterization.
Company Info
INVIVYD INC
1601 Trapelo Road, Suite 178
Waltham MASSACHUSETTS US
Employees: 95
Company Website: https://invivyd.com/
Investor Relations: https://investors.invivyd.com/
Phone: 17818190080
IVVD FAQ
What is the stock price of IVVD?
The current stock price of IVVD is 0.3789 USD.
What is the symbol for INVIVYD INC stock?
The exchange symbol of INVIVYD INC is IVVD and it is listed on the Nasdaq exchange.
On which exchange is IVVD stock listed?
IVVD stock is listed on the Nasdaq exchange.
Is IVVD a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for IVVD, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of IVVD.
Does IVVD stock pay dividends?
IVVD does not pay a dividend.
What is the Price/Earnings (PE) ratio of IVVD?
IVVD does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.96).
What is the Short Interest ratio of IVVD stock?
The outstanding short interest for IVVD is 4.14% of its float.
IVVD Technical Analysis
IVVD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to IVVD. IVVD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
IVVD Financial Highlights
Over the last trailing twelve months IVVD reported a non-GAAP Earnings per Share(EPS) of -1.96. The EPS decreased by -41.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -139.04% | ||
| ROE | -270.72% | ||
| Debt/Equity | 0 |
IVVD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to IVVD. The Buy consensus is the average rating of analysts ratings from 10 analysts.